Registrations Open Now!

ADDS 2027

Ametris Digital Data Summit 2027

February 8-10  |  ATLANTA, GA

WATCH RECAP VIDEO
ADDS 2024

ActiGraph Digital Data Summit 2025

February 10-12     |     Pensacola Beach, FL

Connected Lines Pattern

Advancing Digital Measures Towards Scalable Clinical Impact

Join us for the Ametris Digital Data Summit 2027! Now in its fifth year, ADDS is heading to Atlanta once again to facilitate easier access and expanded space and support our growing community. ADDS is a one-of-a-kind scientific conference advancing the adoption of wearable digital health technologies (DHTs) in clinical research by bringing together a multidisciplinary group of digital health leaders for expert-led presentations and collaborative discussions.

AG_Marketing_ADDS_2022_Icons_KeynoteSpeakers_White

Featured Speakers

  • Ametris_ADDS_2027_Speakers_DanaWolff-Huges

    Dana Wolff-Huges, PhD

    Program Officer

    National Cancer Institute

  • Ametris_ADDS_2027_Speakers_RaulTorres

    Raul Torres, PhD

    Associate Director, Data Science

    Takeda

  • Ametris_ADDS_2027_Speakers_DanielLachant

    Daniel Lachant

    Associate Professor of Medicine

    University of Rochester Medical Center

  • Ametris_ADDS_2027_Speakers_JieRen

    Jie Ren, PhD

    Director, Data Science

    Merck

  • Ametris_ADDS_2027_Speakers_PaulHibbing

    Dr. Paul Hibbing, PhD

    Assistant Professor

    University of Illinois Chicago Department of Kinesiology and Nutrition

Check back regularly for new speakers!

Why Attend ADDS 2027

ADDS is your chance to learn from, network with, and develop collaborations with colleagues from a variety of disciplines, including clinicians, data scientists, clinical trialists, digital health technology specialists, and public health researchers.

Scientific Case Studies

Client Case
Studies

Networking Forums

Networking
Forums

Scientific Poster Sessions

Scientific Poster
Session

Panel Discussions

Panel
Discussions

ADDS 2027 Activity

We're excited to add a new activity to the ADDS agenda this year, providing opportunities for deeper discussions, actionable takeaways, and expanded networking within the digital health community.

Pre-Conference Workshop
Parkinson's Disease

Monday, February 8th

The MDS-UPDRS Part III remains the standard motor endpoint in early Parkinson's disease trials, yet a machine-learned measure from wrist accelerometry has been shown to detect disease progression in prodromal Parkinson’s Disease (PD) more sensitively than this scale — with wearable-sensors elsewhere reaching statistically significant, progression-consistent change within roughly ten months and larger two-year effect sizes than conventional clinical rating in early-stage disease.

This session challenges sponsors to reconsider whether episodic clinical scales alone are sensitive enough for early-population trials, then tailors the evidence to the room: biostatisticians will see the power and sample-size case for continuous digital endpoints; operations leads will see the wear-compliance and data-pipeline requirements; regulatory leads will see how composite construction (reference-based vs. reference-free) affects qualification strength.

The session closes with a clear position: in early and phase I/II PD trials, sensor-based composite measures are a validated complement to clinical rating, not an exploratory add-on — and omitting one risks underpowering detection of true treatment effects.

Seats are limited! Please check the box on the ticket form to reserve your seat.

AG_Marketing_ADDS_2022_Icons_StudentPosterContest_WhiteScientific Poster Session

If you have original, unpublished research that involves the use of digital health technologies (DHTs), including wearables, sensors, and/or eCOA, we invite you to submit your abstract for consideration for ADDS 2027 Scientific Poster Session!

SUBMIT YOUR POSTER

What Did Attendees Say About ADDS?

It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.

Ariel Dowling, PhD

Head of Sensing and Measurement | Takeda

It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.

Johathan Soslow

Pediatric Cardiologist | Vanderbuilt University

An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.

Peter Fernandes

CEO | Bellerophon Therapeutics

I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.

Jennifer Schrack

Professor of Epidemiology and Medicine | Johns Hopkins Bloomberg School of Public Health

Ariel Dowling
Dr. Jonathan Soslow
Peter Fernandes
Jennifer Schrack, PhD

Thank you to our Premier Sponsor

Signant Health